[New drugs approval: Darolutamide - triplet therapy for hormone-sensitive metastastic prostate cancer]

Bull Cancer. 2023 Jun;110(6):599-600. doi: 10.1016/j.bulcan.2023.03.019. Epub 2023 Apr 7.
[Article in French]
No abstract available

Keywords: Cancer de la prostate; Hormone sensitive; Hormonosensible; Metastatic; Métastatique; Prostate cancer; Triplet therapy; Trithérapie.

Publication types

  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Hormones / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy
  • Pyrazoles / therapeutic use

Substances

  • darolutamide
  • Pyrazoles
  • Hormones
  • Androgen Antagonists